Indigenous vaccine COVAXIN ensures immunity

Indigenous vaccine COVAXIN ensures immunity. vaccine COVAXIN, phase 2 results of the booster dose of home-made COVID-19 vaccine, COVAXIN, ensures persistent immunity. “Our goals of developing a global vaccine against COVID-19 have been achieved,” said Dr. Krishna Ella, Chairman and Managing Director of Bharat Biotech, the company that has developed COVAXIN.

vaccine COVAXIN

vaccine COVAXIN booster dose of COVID-19 vaccine is the third dose or the precautionary dose that will be administered as a measure to increase immunity against new variants of the disease inducing coronavirus. It is recommended when the immunity from the initial doses starts to wane. Ideally, it will be the third dose of COVID vaccine. From January 10, India will start giving booster shots to those above 60 years of age with comorbidities.

The booster dose is required to protect the immunocompromised people who did not respond well to the first two doses, to provide protection to the body after a certain duration when the effect of the vaccines start to wane and to trigger the performance of the vaccines against new variants.

For the booster shot which will be given from January 10, certain guidelines will be followed. There will be no mix and match of doses. The booster shot will be of the same vaccine as the first two doses, the government has said. Those who got COVAXIN will get COVAXIN and those who got COVISHIELD will get COVISHIELD.

Articles might you known:

The Delta and Omicron strain of COVID-19